To Assess the Efficacy of Early Administration of Energy Enriched and Protein Enriched Formula in Post Cardiac Repair Infants: a Randomized Controlled Trial, Comparative Study
Congenital Heart Disease in Children, Post-cardiac Surgery, Malnutrition, Infant
About this trial
This is an interventional supportive care trial for Congenital Heart Disease in Children focused on measuring Energy Protein, Enriched, Enteral Nutrition, Cardiac Repair
Eligibility Criteria
Inclusion Criteria: infants born at term, age between 4 weeks and 12 months post congenital heart surgery (RACHS score 2) Exclusion Criteria: syndromic patients if patient is on parenteral nutrition (PN) premature combined inherited metabolic or chromosomal diseases liver and kidney dysfunction before enrollment (index >2 times the upper limit of normal) upper GI activity, vomiting, diarrhea, bloating, and other symptoms before enrollment breastfeeding patients. cow's milk allergy
Sites / Locations
- KFSHRCRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Energy- Protein Enriched Nutritional Formula
Standard Nutritional Formula
Liquid, ready-to-use Energy-Protein nutrition formula with energy density of 1 kCal/mL (EP formula)
Polymeric formula stage-1 and stage-2 for infants aged 0-6 months and 6-12 months accordingly, providing 0.67 kCal/mL (S-1/S-2 formula)